Sino Biological,Inc. (SHE:301047)

Market Cap	7.72B
Revenue (ttm)	616.62M
Net Income (ttm)	100.80M
Shares Out	121.64M
EPS (ttm)	0.80
PE Ratio	79.41
Forward PE	54.98
Dividend	1.00 (1.57%)
Ex-Dividend Date	May 20, 2025

Volume	1,122,085
Average Volume	1,224,005
Open	63.36
Previous Close	63.11
Day's Range	62.70 - 63.99
52-Week Range	53.51 - 87.82
Beta	1.00
RSI	57.25
Earnings Date	Aug 8, 2025

About Sino Biological,Inc.

Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers worldwide. It offers recombinant proteins, antibodies, cDNA clones, kits, and other reagents that are used in the areas of cancer, cardiovascular biology, cell and developmental biology, epigenetics, immunology, neuroscience, signal transduction, and stem cells. The company also provides pre-clinical production technology services for monoclonal antibody drug candidates; and custom services, such as protein production, antibody development and p...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Employees: 1,021
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301047

Financial Performance

In 2024, Sino Biological,Inc.'s revenue was 613.67 million, a decrease of -5.06% compared to the previous year's 646.39 million. Earnings were 121.93 million, a decrease of -53.13%.